OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 14 citing articles:

Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 28

Depression and Anxiety Disorders
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7

Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions
Kenji Hashimoto, Mingming Zhao, Tingting Zhu, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 3, pp. 65-75
Open Access | Times Cited: 11

Efficacy and safety of esketamine for perioperative depression in patients undergoing elective surgery: A meta-analysis of randomized controlled trials
Xue-jie Lou, Di Qiu, Zhuo-Yu Ren, et al.
Asian Journal of Psychiatry (2024) Vol. 95, pp. 103997-103997
Closed Access | Times Cited: 7

Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report
Charles R. Conway, Scott T. Aaronson, Harold A. Sackeïm, et al.
Brain stimulation (2024) Vol. 17, Iss. 2, pp. 448-459
Open Access | Times Cited: 5

Treatment Options for Psychotic Depression in Adolescents: A Comprehensive Review
Violeta Pérez-Rodríguez, Clàudia Aymerich, Ana Catalán, et al.
Psychology Research and Behavior Management (2025) Vol. Volume 18, pp. 197-208
Open Access

Innovative approaches in the treatment-resistant depression: exploring different therapeutic pathways
Anna Łysik, Katarzyna Logoń, Aleksandra Szczygieł, et al.
GeroScience (2025)
Open Access

Atypical antipsychotics in the treatment of depression in affective disorders and schizophrenia (using the aripiprazole model)
I. Yu. Dorozhenok, Alina Strukova
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 4, pp. 36-36
Closed Access

Leserbrief zu: Ketamininfusionstherapie zur Behandlung von Depressionen – Schritt für Schritt
Udo Bonnet
PSYCH up2date (2024) Vol. 18, Iss. 03, pp. 191-192
Closed Access

Antwort zum Leserbrief: Ketamininfusionstherapie zur Behandlung von Depressionen – Schritt für Schritt
Florian Müller‐Dahlhaus, Michael Junginger, Wolfgang Kelsch
PSYCH up2date (2024) Vol. 18, Iss. 03, pp. 193-194
Closed Access

Esketamine Nasal Spray: Rapid Relief for TRD and Suicide Prevention—Mechanisms and Pharmacodynamics
Hui Song, Yang Luo, Lingzhi Fang
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2059-2071
Open Access

Esketamine-Induced Dissociation: A Case Report
Jake Scarcella, Jeffrey S. MacDaniels, Lucinda Coffin, et al.
Journal of Psychoactive Drugs (2024), pp. 1-5
Closed Access

Augmentation mit Ketamin versus anderen Pharmaka – ein Vergleich

PSYCH up2date (2024) Vol. 18, Iss. 06, pp. 446-447
Closed Access

Page 1

Scroll to top